Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
66.00
-0.61 (-0.92%)
Feb 23, 2026, 9:33 AM EST - Market open
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.
Employees
323
Change (1Y)
79
Growth (1Y)
32.38%
Revenue / Employee
$1,133,437
Profits / Employee
-$251,263
Market Cap
2.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
| Sep 30, 2020 | 18 | - | - |
| Jun 30, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 710 |
| Denali Therapeutics | 517 |
| Beam Therapeutics | 510 |
| Travere Therapeutics | 385 |
| Arcutis Biotherapeutics | 342 |
| Vera Therapeutics | 224 |
| Catalyst Pharmaceuticals | 181 |
| Liquidia | 170 |
TARS News
- 5 days ago - Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - GlobeNewsWire
- 5 days ago - Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - GlobeNewsWire
- 18 days ago - Allspring Emerging Growth Fund Q4 2025 Performance Review - Seeking Alpha
- 3 months ago - Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 - Seeking Alpha
- 3 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements - GlobeNewsWire
- 4 months ago - Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewsWire
- 5 months ago - Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off - Seeking Alpha